12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, several healthcare stocks experienced significant movements. Tharimmune (THAR) saw a 19.0% increase, while Amarin Corp (AMRN) rose by 11.63%. Travere Therapeutics (TVTX) increased by 8.42%, iBio (IBIO) by 6.29%, Motus GI Holdings (MOTS) by 5.74%, and Burning Rock Biotech (BNR) by 5.0%. On the downside, Cognition Therapeutics (CGTX) fell by 12.2%, Acrivon Therapeutics (ACRV) by 12.03%, Virpax Pharmaceuticals (VRPX) by 11.75%, Inhibikase Therapeutics (IKT) by 8.81%, 60 Degrees (SXTP) by 6.74%, and Gossamer Bio (GOSS) by 6.07%.
December 04, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Acrivon Therapeutics stock declined by 12.03% to $4.61, with a market cap of $102.3 million.
The drop in Acrivon Therapeutics' stock price could reflect investor worries, potentially leading to a negative short-term trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Cognition Therapeutics stock decreased by 12.2% to $1.23, with a market cap of $38.0 million.
The decline in Cognition Therapeutics' stock price indicates negative investor sentiment, which could lead to further short-term depreciation.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Gossamer Bio stock fell 6.07% to $0.91, with a market value of $205.1 million.
The decline in Gossamer Bio's stock price reflects a negative market reaction, which may lead to further short-term depreciation.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Inhibikase Therapeutics stock decreased by 8.81% to $0.88, with a market cap of $5.4 million.
The decrease in Inhibikase Therapeutics' stock price suggests a negative investor reaction, which may continue to affect the stock in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
60 Degrees shares decreased by 6.74% to $0.65, with a market value of $3.7 million.
The after-market decline in 60 Degrees' stock price could indicate a bearish trend, potentially leading to further short-term losses.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Virpax Pharmaceuticals shares declined by 11.75% to $0.4, with a market cap of $4.6 million.
The significant after-market decline in Virpax Pharmaceuticals' shares could signal a bearish short-term outlook due to negative market sentiment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Amarin Corp shares rose 11.63% to $0.79, with a market cap of $320.8 million.
The after-market rise for Amarin Corp indicates a bullish trend that may persist in the short term, reflecting investor optimism.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Burning Rock Biotech stock rose 5.0% to $0.86, with a market cap of $88.7 million. The company's Q3 earnings were released 2 days ago.
The rise in Burning Rock Biotech's stock following its Q3 earnings release suggests that the earnings may have been received positively, potentially leading to continued short-term upward movement.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
iBio shares moved upwards by 6.29% to $2.87, with a market cap of $4.0 million.
The increase in iBio's shares may attract more attention, potentially leading to a short-term positive trend in its stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Motus GI Holdings shares rose 5.74% to $4.97, with a market cap of $3.4 million.
The positive movement in Motus GI Holdings' stock price could indicate a short-term bullish trend as investor interest grows.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Tharimmune stock increased by 19.0% to $0.87, with a market cap of $2.1 million.
The significant after-market increase in Tharimmune's stock price suggests positive investor sentiment, which could lead to continued short-term upward momentum.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Travere Therapeutics stock increased by 8.42% to $6.82, with a market cap of $512.4 million.
Travere Therapeutics' stock price increase suggests a positive investor response, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90